Regions Financial (RF) Shares Declined While Shapiro Capital Management Has Boosted Holding; Iguana Healthcare Management Has Upped Biogen (BIIB) Position by $3.91 Million

February 15, 2018 - By Ellis Scott

Stuart Weisbrod increased its stake in Biogen Inc (BIIB) by 166.67% based on its latest 2017Q3 regulatory filing with the SEC. Iguana Healthcare Management Llc bought 12,500 shares as the company’s stock declined 13.45% while stock markets rallied. The hedge fund run by Stuart Weisbrod held 20,000 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $6.26 million, up from 7,500 at the end of the previous reported quarter. Iguana Healthcare Management Llc who had been investing in Biogen Inc for a number of months, seems to be bullish on the $63.08 billion market cap company. The stock increased 0.71% or $2.1 during the last trading session, reaching $298.18. About 1.63 million shares traded or 29.30% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 15, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Shapiro Capital Management Llc increased its stake in Regions Financial Corp (RF) by 4.7% based on its latest 2017Q3 regulatory filing with the SEC. Shapiro Capital Management Llc bought 152,030 shares as the company’s stock declined 8.39% while stock markets rallied. The institutional investor held 3.38M shares of the major banks company at the end of 2017Q3, valued at $51.53B, up from 3.23M at the end of the previous reported quarter. Shapiro Capital Management Llc who had been investing in Regions Financial Corp for a number of months, seems to be bullish on the $21.98 billion market cap company. The stock increased 0.05% or $0.01 during the last trading session, reaching $19.38. About 4.10 million shares traded. Regions Financial Corporation (NYSE:RF) has risen 48.79% since February 15, 2017 and is uptrending. It has outperformed by 32.09% the S&P500.

Shapiro Capital Management Llc, which manages about $4.00B and $4399.01 billion US Long portfolio, decreased its stake in Pfizer Inc. (NYSE:PFE) by 57,436 shares to 2.59 million shares, valued at $92.53B in 2017Q3, according to the filing. It also reduced its holding in Usg Corporation (NYSE:USG) by 65,178 shares in the quarter, leaving it with 4.81M shares, and cut its stake in Procter & Gamble Co (NYSE:PG).

Investors sentiment decreased to 0.95 in 2017 Q3. Its down 0.17, from 1.12 in 2017Q2. It dived, as 61 investors sold RF shares while 185 reduced holdings. 58 funds opened positions while 176 raised stakes. 848.03 million shares or 4.66% less from 889.52 million shares in 2017Q2 were reported. Eqis Capital Mngmt holds 15,203 shares. Plancorp Limited Liability Corporation invested in 19,822 shares or 0.09% of the stock. Southeast Asset Advsr holds 0.25% of its portfolio in Regions Financial Corporation (NYSE:RF) for 52,298 shares. Hyman Charles D holds 32,071 shares. Centers Of America invested in 0.04% or 39,779 shares. Howe Rusling Inc holds 0% or 1,007 shares in its portfolio. Credit Agricole S A holds 0.06% or 1.09M shares in its portfolio. Natixis, a France-based fund reported 1.68 million shares. Samlyn Capital Lc stated it has 2.89M shares or 1.11% of all its holdings. Seabridge Investment Advsrs Limited Liability reported 494,491 shares stake. Alpine Woods Capital Invsts Limited Liability holds 0.58% or 746,000 shares. Point72 Asia (Hong Kong) accumulated 0.01% or 1,259 shares. Public Employees Retirement Systems Of Ohio holds 509,670 shares or 0.04% of its portfolio. 19,029 are owned by Ifc Fl. Schneider Cap Mgmt stated it has 1.82% of its portfolio in Regions Financial Corporation (NYSE:RF).

Among 34 analysts covering Regions Financial Corp (NYSE:RF), 9 have Buy rating, 4 Sell and 21 Hold. Therefore 26% are positive. Regions Financial Corp had 108 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, June 6 by Keefe Bruyette & Woods. Guggenheim initiated Regions Financial Corporation (NYSE:RF) on Thursday, October 8 with “Buy” rating. On Tuesday, October 3 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The firm has “Hold” rating given on Friday, January 19 by Susquehanna. PiperJaffray downgraded the stock to “Neutral” rating in Wednesday, November 16 report. Bank of America downgraded the stock to “Neutral” rating in Wednesday, June 29 report. The firm has “Hold” rating by RBC Capital Markets given on Thursday, June 22. The company was maintained on Thursday, August 10 by Wells Fargo. The stock of Regions Financial Corporation (NYSE:RF) has “Hold” rating given on Thursday, September 7 by RBC Capital Markets. The company was downgraded on Tuesday, October 10 by FBR Capital.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It increased, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Cambiar Limited stated it has 1.01% in Biogen Inc. (NASDAQ:BIIB). Raymond James & Assocs, Florida-based fund reported 332,691 shares. Focused Wealth Mngmt Inc holds 850 shares or 0.09% of its portfolio. Moreover, Strs Ohio has 0.4% invested in Biogen Inc. (NASDAQ:BIIB). Channing Cap Mngmt Ltd Liability Co stated it has 25,760 shares. Central National Bank And Trust reported 10,387 shares. Perkins Coie Tru holds 400 shares or 0.06% of its portfolio. Brown Capital Mngmt Lc holds 0.01% or 2,394 shares. Optimum Invest has 1,089 shares. Peddock Advsrs Ltd Limited Liability Company reported 2,374 shares. 4,590 are owned by Greylin Investment Mangement. Cantab Capital Prtn Limited Liability Partnership accumulated 5,369 shares. Montag And Caldwell Ltd reported 1,100 shares stake. Nomura Holdg holds 12,328 shares. Quantbot Technology Limited Partnership owns 3,909 shares.

Iguana Healthcare Management Llc, which manages about $139.00 million and $183.53M US Long portfolio, decreased its stake in Avexis Inc by 12,500 shares to 17,500 shares, valued at $1.69M in 2017Q3, according to the filing. It also reduced its holding in Achaogen Inc (NASDAQ:AKAO) by 30,000 shares in the quarter, leaving it with 30,000 shares, and cut its stake in Lilly Eli & Co (NYSE:LLY).

Since January 9, 2018, it had 0 insider buys, and 1 sale for $1.92 million activity.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>